Table of Content

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION & SCOPE 16
1.2.1 INCLUSIONS AND EXCLUSIONS 16
1.2.2 MARKETS COVERED 17
FIGURE 1 GENETIC TOXICOLOGY TESTING MARKET 17
1.2.3 YEARS CONSIDERED FOR STUDY 17
1.3 CURRENCY 18
1.4 STAKEHOLDERS 18
1.5 LIMITATIONS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.2 KEY DATA FROM SECONDARY SOURCES 21
2.2 PRIMARY RESEARCH 21
2.2.1 PRIMARY SOURCES 22
2.2.1.1 Breakdown of primaries 23
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 23
2.3 MARKET SIZE ESTIMATION 23
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 24
FIGURE 5 MARKET ANALYSIS APPROACH 24
FIGURE 6 TOP-DOWN APPROACH 25
2.4 DATA TRIANGULATION APPROACH 27
FIGURE 7 DATA TRIANGULATION METHODOLOGY 27
2.5 MARKET SHARE ESTIMATION 28
2.6 ASSUMPTIONS FOR STUDY 28

3 EXECUTIVE SUMMARY 29
FIGURE 8 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 29
FIGURE 9 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 30
FIGURE 10 GEOGRAPHIC ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET 31
_

4 PREMIUM INSIGHTS 33
4.1 GENETIC TOXICOLOGY TESTING MARKET OVERVIEW 33
FIGURE 11 INCREASING RESEARCH BEING CONDUCTED USING GENE-BASED TECHNOLOGIES TO DRIVE MARKET GROWTH 33
4.2 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT 34
FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN GENETIC TOXICOLOGY TESTING MARKET IN 2019 34
4.3 GENETIC TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35
FIGURE 13 MARKET IN ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 35
4.4 GENETIC TOXICOLOGY TESTING MARKET, BY REGION (2018–2025) 36
FIGURE 14 NORTH AMERICA TO CONTINUE DOMINATING GENETIC TOXICOLOGY TESTING MARKET UNTIL 2025 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 1 GENETIC TOXICOLOGY SERVICES MARKET: IMPACT ANALYSIS 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increased number of pharmaceutical R&D activities 38
FIGURE 15 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION) 39
5.2.1.2 Opposition to animal testing of drugs and cosmetics 39
5.2.1.3 R&D activities for early toxicity detection in drugs 40
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Lack of validated in vitro models to study complex endpoints 41
5.2.2.2 Reluctance of countries toward replacement of in vivo methods with alternative testing 41
5.2.2.3 Failure of in vitro methods to achieve intricacies similar to in vivo methods 42
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Increased focus on drug discovery and personalized medicines using in vitro methods 42
5.2.3.2 Risen global demand for humanized animal models 43
5.2.4 MARKET CHALLENGES 43
5.2.4.1 Regulations and laws to ensure ethical use of animals in research activities 43
TABLE 2 REGULATORY AUTHORITIES OVERSEEING USE OF ANIMAL MODELS IN RESEARCH ACTIVITIES 44
5.2.4.2 Dearth of skilled professionals 44
5.3 INDUSTRY TRENDS 45
5.3.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY 45
5.4 PARENT MARKET (IN VITRO TOXICOLOGY TESTING): SUPPLY CHAIN ANALYSIS 46
FIGURE 16 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 46
_
5.5 COVID- 19 HEALTH ASSESSMENT 47
FIGURE 17 GLOBAL PROPAGATION OF COVID-19 47
FIGURE 18 COVID-19 PROPAGATION: SELECT COUNTRIES 48
5.6 COVID-19 IMPACT ON GENETIC TOXICOLOGY SERVICES MARKET 48

6 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT 50
6.1 INTRODUCTION 51
FIGURE 19 SERVICES SEGMENT TO LEAD GENETIC TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD 51
TABLE 3 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 51
6.2 SERVICES 52
6.2.1 INCREASED TREND OF OUTSOURCING TOXICITY TESTING SERVICES BY KEY INDUSTRIES SUCH AS PHARMACEUTICALS AND CHEMICALS TO FOSTER MARKET GROWTH 52
TABLE 4 GENETIC TOXICOLOGY SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 53
6.3 REAGENTS AND CONSUMABLES 53
6.3.1 REPETITIVE USE OF CONSUMABLES IN TESTING ACTIVITIES SUPPORTS MARKET GROWTH 53
TABLE 5 GENETIC TOXICOLOGY REAGENTS AND CONSUMABLES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 54
6.4 ASSAYS 54
6.4.1 INCREASED NEED FOR ACCURATE ANALYSIS DRIVES ADOPTION OF DIFFERENT TYPES OF ASSAYS 54
TABLE 6 GENETIC TOXICOLOGY ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 55

7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION 56
7.1 INTRODUCTION 57
7.2 COVID-19 IMPACT, BY APPLICATION 57
FIGURE 20 HEALTHCARE INDUSTRY TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD 58
TABLE 7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 58
7.3 HEALTHCARE INDUSTRY 59
7.3.1 INCREASING R&D INVESTMENTS IN ONCOLOGY FIELD TO BOOST DEMAND FOR GENOTOXICOLOGY TESTING 59
TABLE 8 GENETIC TOXICOLOGY TESTING MARKET FOR HEALTHCARE INDUSTRY,
BY COUNTRY, 2018–2025 (USD MILLION) 60
7.4 FOOD INDUSTRY 60
7.4.1 GROWING FOCUS ON FOOD SAFETY TO PROPEL MARKET GROWTH 60
TABLE 9 GENETIC TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION) 61
7.5 COSMETICS INDUSTRY 62
7.5.1 RISING ADOPTION OF IN VITRO GENOTOXICOLOGY ASSAYS DUE TO BAN ON ANIMAL TESTING FOR COSMETIC PRODUCTS AND INGREDIENTS TO SPUR MARKET GROWTH 62
TABLE 10 GENETIC TOXICOLOGY TESTING MARKET FOR COSMETICS INDUSTRY,
BY COUNTRY, 2018–2025 (USD MILLION) 63
7.6 OTHER INDUSTRIES 63
TABLE 11 GENETIC TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES,
BY COUNTRY, 2018–2025 (USD MILLION) 64

8 GENETIC TOXICOLOGY TESTING MARKET, BY REGION 65
8.1 INTRODUCTION 66
8.2 COVID-19 IMPACT, BY REGION 66
TABLE 12 GENETIC TOXICOLOGY TESTING MARKET, BY REGION,
2018–2025 (USD MILLION) 67
8.3 NORTH AMERICA 67
FIGURE 21 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017 68
FIGURE 22 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT 69
TABLE 13 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 69
TABLE 14 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 70
TABLE 15 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 70
8.3.1 US 70
8.3.1.1 US dominates North American market 70
TABLE 16 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020
(USD BILLION) 71
TABLE 17 US: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 71
TABLE 18 US: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 72
8.3.2 CANADA 72
8.3.2.1 Increasing funding and improved infrastructure for gene-based research supporting market growth 72
TABLE 19 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 73
TABLE 20 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 73
8.4 EUROPE 74
FIGURE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT 75
TABLE 21 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 76
TABLE 22 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 76
TABLE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 76
8.4.1 GERMANY 77
8.4.1.1 Growing R&D activities in genomics to propel market growth 77
TABLE 24 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 78
TABLE 25 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 78
8.4.2 FRANCE 78
8.4.2.1 Increasing government support for gene-based research to support market growth 78
TABLE 26 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 79
TABLE 27 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 79
8.4.3 UK 80
8.4.3.1 Rising public and private funding for research to drive market growth 80
TABLE 28 UK: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 81
TABLE 29 UK: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 81
8.4.4 REST OF EUROPE 81
TABLE 30 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 82
TABLE 31 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 83
8.5 ASIA PACIFIC 83
8.5.1 INCREASING RESEARCH FUNDING AND GROWING AWARENESS ABOUT PERSONALIZED THERAPEUTICS TO SUPPORT MARKET GROWTH 83
TABLE 32 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 85
TABLE 33 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 85
8.6 LATIN AMERICA 85
8.6.1 GROWTH IN PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH 85
TABLE 34 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 86
TABLE 35 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 87
8.7 MIDDLE EAST & AFRICA 87
8.7.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS DRIVING MARKET GROWTH 87
TABLE 36 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET,
BY PRODUCT, 2018–2025 (USD MILLION) 88
TABLE 37 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 88
_

9 COMPETITIVE LANDSCAPE 89
9.1 OVERVIEW 89
FIGURE 24 PRODUCT LAUNCHES?KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2017 TO NOVEMBER 2020 89
9.2 MARKET SHARE ANALYSIS 90
FIGURE 25 GENETIC TOXICOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2019 90
9.3 COMPANY EVALUATION MATRIX 91
9.3.1 STAR 91
9.3.2 EMERGING LEADER 92
9.3.3 PERVASIVE 92
9.3.4 EMERGING COMPANIES 92
FIGURE 26 GENETIC TOXICOLOGY SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 93
9.4 COMPETITIVE SITUATION AND TRENDS 94
9.4.1 EXPANSIONS 94
TABLE 38 EXPANSIONS, 2017–2020 94
9.4.2 ACQUISITIONS 95
TABLE 39 ACQUISITIONS, 2017–2020 95
9.4.3 OTHER STRATEGIES 96
TABLE 40 OTHER STRATEGIES, 2017–2020 96

10 COMPANY PROFILES 97
10.1 THERMO FISHER SCIENTIFIC INC. 97
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019) 97
10.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 99
FIGURE 28 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019) 99
10.3 CREATIVE BIOARRAY 102
10.4 CYPROTEX PLC 103
FIGURE 29 EVOTEC AG: COMPANY SNAPSHOT (2019) 103
10.5 LABORATORY CORP OF AMERICA HOLDINGS 105
FIGURE 30 LABORATORY CORP OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019) 105
10.6 JUBILANT LIFE SCIENCES LIMITED 107
FIGURE 31 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2020) 107
10.7 MERCK KGAA (MILLIPORE SIGMA ) 109
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019) 109
10.8 SHANGHAI MEDICILON INC. 112
10.9 EUROFINS SCIENTIFIC 113
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 113
10.10 CREATIVE BIOLABS 115
10.11 TOXIKON CORPORATION 116
10.12 ENVIRONMENTAL BIO-DETECTION PRODUCTS INC. (EBPI) 118
10.13 GENTRONIX LIMITED 119
10.14 MB RESEARCH LABORATORIES 121
10.15 SOTERA HEALTH LLC 122

11 APPENDIX 124
11.1 INSIGHTS OF INDUSTRY EXPERTS 124
11.2 DISCUSSION GUIDE 125
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 128
11.4 AVAILABLE CUSTOMIZATIONS 130
11.5 RELATED REPORTS 130
11.6 AUTHOR DETAILS 131

_
List of Tables

TABLE 1 GENETIC TOXICOLOGY SERVICES MARKET: IMPACT ANALYSIS 36
TABLE 2 REGULATORY AUTHORITIES OVERSEEING USE OF ANIMAL MODELS IN RESEARCH ACTIVITIES 43
TABLE 3 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 50
TABLE 4 GENETIC TOXICOLOGY SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 52
TABLE 5 GENETIC TOXICOLOGY REAGENTS AND CONSUMABLES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 53
TABLE 6 GENETIC TOXICOLOGY ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 54
TABLE 7 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 57
TABLE 8 GENETIC TOXICOLOGY TESTING MARKET FOR HEALTHCARE INDUSTRY,
BY COUNTRY, 2018–2025 (USD MILLION) 59
TABLE 9 GENETIC TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 10 GENETIC TOXICOLOGY TESTING MARKET FOR COSMETICS INDUSTRY,
BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 11 GENETIC TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 12 GENETIC TOXICOLOGY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 66
TABLE 13 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 68
TABLE 14 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 69
TABLE 15 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 69
TABLE 16 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020 (USD BILLION) 70
TABLE 17 US: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 70
TABLE 18 US: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 71
TABLE 19 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 72
TABLE 20 CANADA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 72
TABLE 21 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 75
TABLE 22 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 75
TABLE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 75
TABLE 24 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 77
TABLE 25 GERMANY: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 77
TABLE 26 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 78
TABLE 27 FRANCE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 78
TABLE 28 UK: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 80
TABLE 29 UK: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 80
TABLE 30 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 81
TABLE 31 ROE: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 82
TABLE 32 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 84
TABLE 33 ASIA PACIFIC: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 84
TABLE 34 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 85
TABLE 35 LATIN AMERICA: GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 86
TABLE 36 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 87
TABLE 37 MIDDLE EAST & AFRICA: GENETIC TOXICOLOGY TESTING MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 87
TABLE 38 EXPANSIONS, 2017–2020 93
TABLE 39 ACQUISITIONS, 2017–2020 94
TABLE 40 OTHER STRATEGIES, 2017–2020 95


LIST OF FIGURES

FIGURE 1 GENETIC TOXICOLOGY TESTING MARKET 16
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 23
FIGURE 5 MARKET ANALYSIS APPROACH 23
FIGURE 6 TOP-DOWN APPROACH 24
FIGURE 7 DATA TRIANGULATION METHODOLOGY 26
FIGURE 8 GENETIC TOXICOLOGY TESTING MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 28
FIGURE 9 GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 29
FIGURE 10 GEOGRAPHIC ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET 30
FIGURE 11 INCREASING RESEARCH BEING CONDUCTED USING GENE-BASED TECHNOLOGIES TO DRIVE MARKET GROWTH 32
FIGURE 12 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN GENETIC TOXICOLOGY TESTING MARKET IN 2019 33
FIGURE 13 MARKET IN ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING
FORECAST PERIOD 34
FIGURE 14 NORTH AMERICA TO CONTINUE DOMINATING GENETIC TOXICOLOGY TESTING MARKET UNTIL 2025 35
FIGURE 15 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION) 38
FIGURE 16 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 45
FIGURE 17 GLOBAL PROPAGATION OF COVID-19 46
FIGURE 18 COVID-19 PROPAGATION: SELECT COUNTRIES 47
FIGURE 19 SERVICES SEGMENT TO LEAD GENETIC TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD 50
FIGURE 20 HEALTHCARE INDUSTRY TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD 57
FIGURE 21 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017 67
FIGURE 22 NORTH AMERICA: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT 68
FIGURE 23 EUROPE: GENETIC TOXICOLOGY TESTING MARKET SNAPSHOT 74
FIGURE 24 PRODUCT LAUNCHES?KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2017 TO NOVEMBER 2020 88
FIGURE 25 GENETIC TOXICOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2019 89
FIGURE 26 GENETIC TOXICOLOGY SERVICES MARKET: COMPETITIVE LEADERSHIP
MAPPING (2019) 92
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019) 96
FIGURE 28 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY
SNAPSHOT (2019) 98
FIGURE 29 EVOTEC AG: COMPANY SNAPSHOT (2019) 102
FIGURE 30 LABORATORY CORP OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019) 104

FIGURE 31 JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT (2020) 106
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019) 108
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 112